Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease.
Saved in:
| Title: | Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease. |
|---|---|
| Authors: | Ortiz-Maldonado V; Department of Hematology, Hospital Clínic, Barcelona, Spain.; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Alonso-Saladrigues A; CAR T-cell Unit, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Leukemia & Pediatric Hematological Disorders, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Español-Rego M; Department of Immunology, Hospital Clínic, Barcelona, Spain., Martínez-Cibrián N; Department of Hematology, Hospital Clínic, Barcelona, Spain., Faura A; CAR T-cell Unit, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Magnano L; Department of Hematology, Hospital Clínic, Barcelona, Spain.; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Català A; CAR T-cell Unit, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Leukemia & Pediatric Hematological Disorders, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain., Benítez-Ribas D; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Immunology, Hospital Clínic, Barcelona, Spain., Giné E; Department of Hematology, Hospital Clínic, Barcelona, Spain.; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Díaz-Beyá M; Department of Hematology, Hospital Clínic, Barcelona, Spain.; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Correa JG; Department of Hematology, Hospital Clínic, Barcelona, Spain., Rovira M; Department of Hematology, Hospital Clínic, Barcelona, Spain.; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Montoro-Lorite M; Department of Hematology, Hospital Clínic, Barcelona, Spain., Martínez-Roca A; Department of Hematology, Hospital Clínic, Barcelona, Spain., Rodríguez-Lobato LG; Department of Hematology, Hospital Clínic, Barcelona, Spain.; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Cabezón R; Department of Immunology, Hospital Clínic, Barcelona, Spain., Cid J; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Apheresis Unit, Hospital Clínic, Barcelona, Spain., Lozano M; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Apheresis Unit, Hospital Clínic, Barcelona, Spain.; Department of Medicine, Universitat de Barcelona, Barcelona, Spain., Garcia-Rey E; Apheresis Unit, Banc de Sang i Teixits, Barcelona, Spain., Conde N; CAR T-cell Unit, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Pedrals G; CAR T-cell Unit, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Rozman M; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematopathology Unit, Hospital Clínic, Barcelona, Spain., Torrebadell M; CAR T-cell Unit, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Leukemia & Pediatric Hematological Disorders, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Hematology Laboratory, Hospital Sant Joan de Deu, Barcelona, Spain., Setoain X; Department of Medicine, Universitat de Barcelona, Barcelona, Spain.; Department of Nuclear Medicine, Hospital Clínic, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain., Rodríguez S; Department of Radiology, Hospital Clínic, Barcelona, Spain., Esteve J; Department of Hematology, Hospital Clínic, Barcelona, Spain.; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Pascal M; Department of Immunology, Hospital Clínic, Barcelona, Spain.; Immunotherapy Platform, Hospital Clínic-Sant Joan de Déu, Barcelona, Spain., Urbano-Ispizua Á; Department of Hematology, Hospital Clínic, Barcelona, Spain.; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Medicine, Universitat de Barcelona, Barcelona, Spain., Juan M; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Immunology, Hospital Clínic, Barcelona, Spain.; Department of Medicine, Universitat de Barcelona, Barcelona, Spain.; Immunotherapy Platform, Hospital Clínic-Sant Joan de Déu, Barcelona, Spain., Delgado J; Department of Hematology, Hospital Clínic, Barcelona, Spain.; Oncology & Haematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Medicine, Universitat de Barcelona, Barcelona, Spain., Rives S; CAR T-cell Unit, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Leukemia & Pediatric Hematological Disorders, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain. |
| Source: | American journal of hematology [Am J Hematol] 2022 Jun 01; Vol. 97 (6), pp. 731-739. Date of Electronic Publication: 2022 Mar 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-8652 |
|---|---|
| DOI: | 10.1002/ajh.26519 |
